The Circle of Willis (CoW) is a ring like structure located at the base of brain, which is composed of a single anterior communicating artery (ACoA), paired anterior cerebral arteries (ACAs), paired internal carotid arteries (ICAs), paired posterior communicating arteries (PCoAs), paired posterior cerebral arteries (PCAs), paired vertebral arteries (VAs) and a single basilar artery (BA). It is the main cerebral blood perfusion pathway and provides an important collateral channel in patients with severe carotid or vertebral artery disease. Over 50% of stroke cases are related to the stenosis of arteries in the CoW, so the detailed information of the cerebral hemodynamics under different pathology situations is important for a variety of clinical applications. Numerous experimental studies have been performed on this field from different perspectives, include the mechanism of stenosis in the CoW , risk assessment of cerebral aneurysm  and the impact of pathological variations on the flow distribution . However, none of these researches focus on the influence of ICA stenosis rates on cerebral perfusion and the specific collateral mechanism of the Circle of Willis under such situations. In this paper, an experimental study on cerebral blood perfusion and the collateral mechanism under a series of ICA stenosis rates was carried out.
- Bioengineering Division
Experimental Study of Hemodynamics in the Circle of Willis
- Views Icon Views
- Share Icon Share
- Search Site
Zhu, G, Yuan, Q, & Yeo, JH. "Experimental Study of Hemodynamics in the Circle of Willis." Proceedings of the ASME 2013 Summer Bioengineering Conference. Volume 1A: Abdominal Aortic Aneurysms; Active and Reactive Soft Matter; Atherosclerosis; BioFluid Mechanics; Education; Biotransport Phenomena; Bone, Joint and Spine Mechanics; Brain Injury; Cardiac Mechanics; Cardiovascular Devices, Fluids and Imaging; Cartilage and Disc Mechanics; Cell and Tissue Engineering; Cerebral Aneurysms; Computational Biofluid Dynamics; Device Design, Human Dynamics, and Rehabilitation; Drug Delivery and Disease Treatment; Engineered Cellular Environments. Sunriver, Oregon, USA. June 26–29, 2013. V01AT05A006. ASME. https://doi.org/10.1115/SBC2013-14162
Download citation file: